Trademark: 79296324
Word
ORPHALAN INNOVATION FOR ORPHAN DISEASES
Status Date
Tuesday, December 28, 2021
Registration Number
6599549
Registration Date
Tuesday, December 28, 2021
Filing Date
Wednesday, September 9, 2020
Published for Opposition
Tuesday, October 12, 2021
5 diagnostic agents for pharmaceutical use; capsules sold empty for pharmaceutical use; pharmaceutical compounds for the treatment of orphan diseases; pharmaceutical products for the treatment of orphan diseases; chemical preparations for pharmaceutical use, namely, for the treatment of orphan diseases; chemical preparations for medical use, for the treatment of orphan diseases; medicines for the development of treatment for orphan diseases
44 Advice relating to pharmacy, namely, advice relating to the use of pharmaceuticals for the treatment of orphan diseases; advisory services relating to health; pharmaceutical advice; advice relating to medicines; information to patients on administering medicines; medical information; drug use testing service for medical use; pharmaceutical services, namely, pharmaceutical compounding services and information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; medical testing and analysis services for diagnostic or treatment of orphan disease; health advisory services relating to the use and operation of medical apparatus and instruments for treatment of orphan disease; medical diagnosis of orphan diseases
10 Medical apparatus and instruments for diagnosing and treating orphan diseases; surgical apparatus and instruments; diagnostic apparatus for medical use for diagnosing orphan diseases; immunochemical testing apparatus for medical use; medical testing instruments for diagnosing and treating orphan diseases; substance analysis apparatus, namely, medical devices and medical instruments for the analysis of body fluids; instruments for extraction of liquids from the human body, namely, medical devices for obtaining body fluid samples; blood testing apparatus; radiology apparatus for medical use; blood testing instruments, namely, needles for medical use and veterinary use; resuscitation apparatus; gloves for medical use; gloves for veterinary use; syringes for medical use; fluid injectors for medical use; X-rays for medical use; inhalers for medical use; radiology screens for medical use; containers for applying medicines being medical tubing for administering drugs; special containers for medical waste; probes for medical use; thermometers for medical use; medical cases, namely, cases fitted for medical instruments; stethoscopes; heart pacemakers; electromagnetic diagnostic imaging apparatus for medical use; needles for medical use
42 Development of pharmaceutical preparations and medicines; development of pharmaceutical products; providing information on clinical studies for pharmaceutical products via an interactive website; evaluation of pharmaceutical products; scientific research in the field of pharmacy; research regarding pharmaceutical products; pharmaceutical research and development; research relating to pharmaceutical products; research and development for the pharmaceutical industry; conducting clinical trials for other in the field of pharmaceutical products; pharmaceutical drug development services; laboratory research services relating to pharmaceutical products; pharmaceutical research services; medical and pharmacological research services; pharmaceutical research and development services; Scientific research for medical purposes; scientific laboratory services; research and development in the field of biotechnology; design and development of medical diagnostic apparatus
The mark consists of a navy blue drop and light purple drop facing each other at its points. To the top left of the drops is a sky blue square with its upper left vertex rounded. To the bottom right of the drops is a purple circle. To the right of the aforementioned elements is the stylized navy blue wording "ORPHALAN" followed by a grey vertical band with the stylized stacked sky blue wording "INNOVATION FOR ORPHAN DISEASES" following the vertical band.
The colors navy blue, sky blue, purple, light purple and gray are claimed as a feature of the mark.
"INNOVATION FOR ORPHAN DISEASES"
Jul 5, 2022
Final Decision Transaction Processed By Ib
Jun 9, 2022
Final Disposition Notice Sent To Ib
Jun 9, 2022
Final Disposition Processed
Mar 28, 2022
Final Disposition Notice Created, To Be Sent To Ib
Dec 28, 2021
Registered-Principal Register
Oct 12, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Published For Opposition
Sep 22, 2021
Notification Of Notice Of Publication E-Mailed
Sep 7, 2021
Approved For Pub - Principal Register
Sep 3, 2021
Examiner's Amendment Entered
Sep 3, 2021
Notification Of Examiners Amendment E-Mailed
Sep 3, 2021
Examiners Amendment E-Mailed
Sep 3, 2021
Examiners Amendment -Written
Aug 4, 2021
Teas/Email Correspondence Entered
Aug 4, 2021
Correspondence Received In Law Office
Aug 4, 2021
Teas Request For Reconsideration Received
Apr 22, 2021
Notification Of Final Refusal Emailed
Apr 22, 2021
Final Refusal E-Mailed
Apr 22, 2021
Final Refusal Written
Apr 10, 2021
Change Of Name/Address Rec'd From Ib
Mar 27, 2021
Teas/Email Correspondence Entered
Mar 26, 2021
Correspondence Received In Law Office
Mar 26, 2021
Teas Response To Office Action Received
Mar 1, 2021
Refusal Processed By Ib
Feb 8, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Feb 8, 2021
Refusal Processed By Mpu
Jan 28, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jan 27, 2021
Non-Final Action Written
Jan 19, 2021
Assigned To Examiner
Oct 30, 2020
Application Filing Receipt Mailed
Oct 26, 2020
New Application Office Supplied Data Entered In Tram
Oct 22, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
